A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer (Q82672762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

James Lewis Abbruzzese

11

object named as

James L Abbruzzese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

Fazlul H Sarkar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Bassel Fuad El-Rayes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Philip A Philip

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Anthony F Shields

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ann Marie Ferris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kenneth Hess

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ahmad O Kaseb

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Milind M Javle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gauri R Varadhachary

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Robert A Wolff

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

27 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

694-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20107864%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-010-9386-6

17 January 2020

exact match

0 references

cites work

The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells

1 reference

12 December 2020

Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner

1 reference

12 December 2020

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer.

1 reference

12 December 2020

Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.

1 reference

12 December 2020

Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein

1 reference

12 December 2020

Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway

1 reference

12 December 2020

Systemic therapy for advanced pancreatic cancer

1 reference

12 December 2020

Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer

1 reference

12 December 2020

Gene expression profiles of genistein-treated PC3 prostate cancer cells

1 reference

12 December 2020

The PI3K-PDK1 connection: more than just a road to PKB

1 reference

12 December 2020

Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA

1 reference

12 December 2020

Optimal two-stage designs for phase II clinical trials

1 reference

12 December 2020

Genistein elicits pleiotropic molecular effects on head and neck cancer cells

1 reference

12 December 2020

New exchange, new target

1 reference

12 December 2020

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis

1 reference

12 December 2020

Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer

1 reference

12 December 2020

Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes

1 reference

12 December 2020

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide

1 reference

12 December 2020

Complementary and Alternative Therapies for Cancer

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line

1 reference

12 December 2020

Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

1 reference

12 December 2020

Soy isoflavones in the treatment of prostate cancer

1 reference

12 December 2020

Mechanisms of cancer chemoprevention by soy isoflavone genistein

1 reference

12 December 2020